Despite shortcomings, contrast-enhanced MR angiography prevailed over digital subtraction angiography often enough in a head-to-head trial to become the modality of choice for investigations of suspected infrapopliteal occlusive disease at New York-Weill Cornell Medical Center.
Despite shortcomings, contrast-enhanced MR angiography prevailed over digital subtraction angiography often enough in a head-to-head trial to become the modality of choice for investigations of suspected infrapopliteal occlusive disease at New York-Weill Cornell Medical Center.
Dr. Honglei Zhang, a radiologist at Weill, laid out the rationale for revisions to her department's policy at the International Society for Magnetic Resonance in Medicine meeting in Miami. Her study of 52 patients produced almost identical results for 2D projection MRA performed on a 1.5T scanner and DSA exams for the popliteal arteries. MRA was less robust for detecting occlusive arterial disease in the feet.
The overall sensitive and specificity of MRA to significant stenosis were 84% and 95%, respectively, in the calf and 79% and 71% in the foot. For arterial occlusion, the sensitivity and specificity of MRA rose to 89% and 95%, respectively, in the calf and 79% and 86% in the foot.
"In the calf, MRA tends to undergrade the severity, but in the foot, the possibility of undergrading and overgrading is nearly identical," Zhang said.
A reexamination of the 105 instances in which DSA and MRA disagreed found the differences in physician interpretation in 43 segments came from borderline lesions that could easily be graded either way, she said. In 22 segments, the reviewers decided MRA was more likely to be correct than DSA. DSA image quality was poor in three of those instances and suffered inadequate x-ray contrast opacification in the rest.
"This indicates that DSA is not perfect as a gold standard, and the real accuracy of MRA may be higher than was shown here," Zhang said.
The accuracy of MRA, especially in smaller distal vessels, may improve as better acquisition techniques such as 3D TRICKS and VIPR and better reconstruction techniques are introduced, she said.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
New Literature Review Assesses Merits of Cardiac MRI After Survival of Sudden Cardiac Arrest
April 19th 2024While noting inconsistencies with the diagnostic yield of cardiac MRI in patients who survived sudden cardiac arrest, researchers cited unique advantages in characterizing ischemic cardiomyopathy (ICM) and facilitating alternate diagnoses.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.